Skip to main content

LifeTech Scientific Corporation (LFTSF)

New York Stock Exchange Healthcare Medical - DevicesView data quality →
56.0Fair

ValueMarkers Composite Index

Top 58%#18,707 of 44,722
Overvalued

361% above intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
4/9
Neutral
Beneish
-1.83
Investigate
Altman
1.73
Distress
DCF Value
$0
Overvalued
ROIC
3.6%
Low
P/E
48.9
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

LifeTech Scientific Corporation (LFTSF) — VMCI valuation read

Across 120 indicators, LifeTech Scientific Corporation (LFTSF) lands at VMCI 56/100. The Healthcare sector median is 50, so the 6-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on LFTSF in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, LFTSF trades at 17.0x earnings, 6% below the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of -1.7x leaves covenant headroom for LFTSF on the trailing balance sheet.

LFTSF rose 1.8% over the trailing 7 days, with a +8.0% read on a 30-day basis.

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; manufacturing and trading of materials for hemp; staff training and internal personnel management business; information consulting for investors; and manufacturing and trading of medical devices, as well as technical, consulting, and technology services. It has operations in Mainland China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.

CEO: Yuehui Xie1,395 employeesCNwww.lifetechmed.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.